Interventional Ablation for Early-stage Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

656

Participants

Timeline

Start Date

April 12, 2025

Primary Completion Date

December 21, 2028

Study Completion Date

December 31, 2028

Conditions
Lung Cancer (NSCLC)Early Stage Lung Non-Small Cell Carcinoma
Trial Locations (1)

520000

Guangzhou Institute of Respiratory Disease (Responsible Party), Guangzhou

All Listed Sponsors
collaborator

Hunan Provincial People's Hospital

OTHER

collaborator

Beijing Chao Yang Hospital

OTHER

collaborator

Fuda Cancer Hospital, Guangzhou

OTHER

collaborator

University of South China Affiliated Nanhua Hospital

UNKNOWN

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Eastern Theater General Hospital,QinHuai District Medical Area

UNKNOWN

collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

Emergency General Hospital

OTHER

collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

The Second Hospital of Anhui Medical University

OTHER

collaborator

Huaxi Hospital

OTHER

collaborator

Shanghai Chest Hospital

OTHER

collaborator

Military 301 Hospital

UNKNOWN

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

lead

Guangzhou Institute of Respiratory Disease

OTHER